EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
Clinical trial NCT05093634 · COMPLETED
Trial details
- NCT number
- NCT05093634
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2025-12-22
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.